201 related articles for article (PubMed ID: 38454605)
1. The extracellular cyclophilin A-integrin β2 complex as a therapeutic target of viral pneumonia.
Bai X; Yang W; Zhao Y; Cao T; Lin R; Jiao P; Li H; Li H; Min J; Jia X; Zhang H; Fan W; Jia X; Bi Y; Liu W; Sun L
Mol Ther; 2024 May; 32(5):1510-1525. PubMed ID: 38454605
[TBL] [Abstract][Full Text] [Related]
2. Secreted Extracellular Cyclophilin A Is a Novel Mediator of Ventilator-induced Lung Injury.
Koh MW; Baldi RF; Soni S; Handslip R; Tan YY; O'Dea KP; Malesevic M; McAuley DF; O'Kane CM; Patel BV; Takata M; Wilson MR
Am J Respir Crit Care Med; 2021 Aug; 204(4):421-430. PubMed ID: 33848447
[No Abstract] [Full Text] [Related]
3. [Effect of extracellular cyclophilin A on inflammatory response and anti-inflammatory activity of antibody against cyclophilin A].
Li W; Liu W; Chen C; Fan W; Zhang H; Liu W; Sun L
Sheng Wu Gong Cheng Xue Bao; 2018 Jan; 34(1):90-101. PubMed ID: 29380574
[TBL] [Abstract][Full Text] [Related]
4.
Li L; Luo D; Liao Y; Peng K; Zeng Y
Front Immunol; 2020; 11():2052. PubMed ID: 33013867
[No Abstract] [Full Text] [Related]
5. Cyclophilin A causes severe fever with thrombocytopenia syndrome virus-induced cytokine storm by regulating mitogen-activated protein kinase pathway.
Huang H; Jin K; Ouyang K; Jiang Z; Yang Z; Hu N; Dai Y; Zhang Y; Zhang Q; Han Y; Zhao J; Lin H; Wang C; Wang C; Sun X; Lu D; Zhu J; Li J
Front Microbiol; 2022; 13():1046176. PubMed ID: 36569095
[TBL] [Abstract][Full Text] [Related]
6. Induction of cyclophilin A by influenza A virus infection facilitates group A Streptococcus coinfection.
Bai X; Yang W; Luan X; Li H; Li H; Tian D; Fan W; Li J; Wang B; Liu W; Sun L
Cell Rep; 2021 May; 35(7):109159. PubMed ID: 34010655
[TBL] [Abstract][Full Text] [Related]
7. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
8. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2-Induced Inflammation.
Yang F; Liu C; Li P; Wu A; Ma-Lauer Y; Zhang H; Su Z; Lu W; von Brunn A; Zhu D
Mol Pharmacol; 2023 Dec; 104(6):239-254. PubMed ID: 37827578
[TBL] [Abstract][Full Text] [Related]
9. Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia.
Ito T; Itakura J; Takahashi S; Sato M; Mino M; Fushimi S; Yamada M; Morishima T; Kunkel SL; Matsukawa A
Crit Care Med; 2016 Jul; 44(7):e530-43. PubMed ID: 26757161
[TBL] [Abstract][Full Text] [Related]
10. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
Sallenave JM; Guillot L
Front Immunol; 2020; 11():1229. PubMed ID: 32574272
[TBL] [Abstract][Full Text] [Related]
11. The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.
Zhu D; Wang Z; Zhao JJ; Calimeri T; Meng J; Hideshima T; Fulciniti M; Kang Y; Ficarro SB; Tai YT; Hunter Z; McMilin D; Tong H; Mitsiades CS; Wu CJ; Treon SP; Dorfman DM; Pinkus G; Munshi NC; Tassone P; Marto JA; Anderson KC; Carrasco RD
Nat Med; 2015 Jun; 21(6):572-80. PubMed ID: 26005854
[TBL] [Abstract][Full Text] [Related]
12. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma.
Geng J; Chen L; Yuan Y; Wang K; Wang Y; Qin C; Wu G; Chen R; Zhang Z; Wei D; Du P; Zhang J; Lin P; Zhang K; Deng Y; Xu K; Liu J; Sun X; Guo T; Yang X; Wu J; Jiang J; Li L; Zhang K; Wang Z; Zhang J; Yan Q; Zhu H; Zheng Z; Miao J; Fu X; Yang F; Chen X; Tang H; Zhang Y; Shi Y; Zhu Y; Pei Z; Huo F; Liang X; Wang Y; Wang Q; Xie W; Li Y; Shi M; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2021 Sep; 6(1):347. PubMed ID: 34564690
[TBL] [Abstract][Full Text] [Related]
13. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications.
Pelaia C; Tinello C; Vatrella A; De Sarro G; Pelaia G
Ther Adv Respir Dis; 2020; 14():1753466620933508. PubMed ID: 32539627
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
15. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A Regulates Influenza A Virus-induced Macrophages Polarization and Inflammatory Responses by Targeting Cyclophilin A.
Bai X; Yang W; Li H; Zhao Y; Fan W; Zhang H; Liu W; Sun L
Front Immunol; 2022; 13():861292. PubMed ID: 35693825
[TBL] [Abstract][Full Text] [Related]
18. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
[TBL] [Abstract][Full Text] [Related]
19. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.
Gebremeskel S; Schanin J; Coyle KM; Butuci M; Luu T; Brock EC; Xu A; Wong A; Leung J; Korver W; Morin RD; Schleimer RP; Bochner BS; Youngblood BA
Front Immunol; 2021; 12():650331. PubMed ID: 33777047
[TBL] [Abstract][Full Text] [Related]
20. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
